Target intelligence / Profile preview

MicroRNA 3117 (MIR3117)

Target
MIR3117
Molecular classification
microRNA, non-coding RNA
01

Overview

MicroRNA 3117 is a short, non-coding RNA molecule (20–24 nucleotides) classified as a microRNA. It is transcribed as a primary transcript (pri-miRNA), which is processed by Drosha and Dicer enzymes to yield the mature miRNA. This mature form is loaded onto an RNA-induced silencing complex (RISC), which uses base-pair complementarity to recognize and regulate stability and translation of target mRNAs, resulting in translational inhibition or destabilization of the target mRNA[1][4]. MIR3117 is implicated in regulating cell proliferation and may target specific mRNAs involved in cancer, such as hepatocellular carcinoma[1]. There is also evidence from transcriptomic profiling indicating roles for microRNAs (including MIR3117 and related molecules) as biomarkers or regulators in breast cancer molecular subtypes[3].

Other names
hsa-mir-3117mir-3117MIR3117
02

Biological functions

post-transcriptional regulation of gene expressioncell proliferation
03

Disease associations

cancer (including hepatocellular carcinoma[1])possible role in breast cancer according to related miRNA profiling studies[3]
04

Biomarkers

MIR3117 (candidate biomarker in certain studies[3])

Beyond the preview

Go deeper on MicroRNA 3117 (MIR3117).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 3117 (MIR3117).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call